| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 7587304
[patent_doc_number] => 20110281814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-17
[patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING BREAST CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/146287
[patent_app_country] => US
[patent_app_date] => 2010-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13332
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20110281814.pdf
[firstpage_image] =>[orig_patent_app_number] => 13146287
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/146287 | METHODS AND COMPOSITIONS FOR TREATING BREAST CANCER | Jan 27, 2010 | Abandoned |
Array
(
[id] => 8232861
[patent_doc_number] => 08198303
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-06-12
[patent_title] => 'Methods of use and compositions for the diagnosis and treatment of infectious diseases'
[patent_app_type] => utility
[patent_app_number] => 12/693252
[patent_app_country] => US
[patent_app_date] => 2010-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 44
[patent_no_of_words] => 8241
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/198/08198303.pdf
[firstpage_image] =>[orig_patent_app_number] => 12693252
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/693252 | Methods of use and compositions for the diagnosis and treatment of infectious diseases | Jan 24, 2010 | Issued |
Array
(
[id] => 7766109
[patent_doc_number] => 20120034193
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-09
[patent_title] => 'TREATMENT OF NEUROTROPHIC FACTOR MEDIATED DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 13/138251
[patent_app_country] => US
[patent_app_date] => 2010-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 32921
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20120034193.pdf
[firstpage_image] =>[orig_patent_app_number] => 13138251
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/138251 | TREATMENT OF NEUROTROPHIC FACTOR MEDIATED DISORDERS | Jan 21, 2010 | Abandoned |
Array
(
[id] => 6266874
[patent_doc_number] => 20100298304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-25
[patent_title] => 'DIAGNOSIS AND TREATMENT OF AUTISM SPECTRUM DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/688171
[patent_app_country] => US
[patent_app_date] => 2010-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 18292
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20100298304.pdf
[firstpage_image] =>[orig_patent_app_number] => 12688171
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/688171 | Diagnosis of autism spectrum disorders and its treatment with an antagonist or inhibitor of the 5-HT2c receptor signaling pathway | Jan 14, 2010 | Issued |
Array
(
[id] => 8313717
[patent_doc_number] => 20120190738
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-26
[patent_title] => 'INHIBITORS OF PHOSPHATIDYLINOSITOL-3-KINASE (PI3) AND INDUCERS OF NITRIC OXIDE (NO)'
[patent_app_type] => utility
[patent_app_number] => 13/144263
[patent_app_country] => US
[patent_app_date] => 2010-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11852
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13144263
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/144263 | Inhibitors of phosphatidylinositol-3-kinase (PI3) and inducers of nitric oxide (NO) | Jan 11, 2010 | Issued |
Array
(
[id] => 10844614
[patent_doc_number] => 08871791
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-10-28
[patent_title] => 'Narcotic emulsion formulations for treatment of cancer pain'
[patent_app_type] => utility
[patent_app_number] => 12/685401
[patent_app_country] => US
[patent_app_date] => 2010-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7187
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12685401
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/685401 | Narcotic emulsion formulations for treatment of cancer pain | Jan 10, 2010 | Issued |
Array
(
[id] => 9964865
[patent_doc_number] => 09012477
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-21
[patent_title] => 'Method of treating neuropathic pain'
[patent_app_type] => utility
[patent_app_number] => 12/652502
[patent_app_country] => US
[patent_app_date] => 2010-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5643
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 205
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12652502
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/652502 | Method of treating neuropathic pain | Jan 4, 2010 | Issued |
Array
(
[id] => 6163067
[patent_doc_number] => 20110160166
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-30
[patent_title] => 'Therapeutic composition for the treatment and prevention of athlete\'s foot and fungal infections of the nail and surrounding tissues'
[patent_app_type] => utility
[patent_app_number] => 12/651410
[patent_app_country] => US
[patent_app_date] => 2009-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2409
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20110160166.pdf
[firstpage_image] =>[orig_patent_app_number] => 12651410
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/651410 | Therapeutic composition for the treatment and prevention of athlete's foot and fungal infections of the nail and surrounding tissues | Dec 30, 2009 | Abandoned |
Array
(
[id] => 5973181
[patent_doc_number] => 20110152343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-23
[patent_title] => 'PROTEASE INHIBITORS AND BROAD-SPECTRUM ANTIVIRAL'
[patent_app_type] => utility
[patent_app_number] => 12/644402
[patent_app_country] => US
[patent_app_date] => 2009-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5560
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20110152343.pdf
[firstpage_image] =>[orig_patent_app_number] => 12644402
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/644402 | PROTEASE INHIBITORS AND BROAD-SPECTRUM ANTIVIRAL | Dec 21, 2009 | Abandoned |
Array
(
[id] => 6615129
[patent_doc_number] => 20100099656
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-22
[patent_title] => 'Neurotherapeutic compositions'
[patent_app_type] => utility
[patent_app_number] => 12/653842
[patent_app_country] => US
[patent_app_date] => 2009-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3463
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20100099656.pdf
[firstpage_image] =>[orig_patent_app_number] => 12653842
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/653842 | Neurotherapeutic compositions | Dec 17, 2009 | Abandoned |
Array
(
[id] => 10062802
[patent_doc_number] => 09101631
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-11
[patent_title] => 'Combination therapy based on SRC and aurora kinase inhibition for the treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 13/139441
[patent_app_country] => US
[patent_app_date] => 2009-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5364
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13139441
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/139441 | Combination therapy based on SRC and aurora kinase inhibition for the treatment of cancer | Dec 13, 2009 | Issued |
Array
(
[id] => 7566906
[patent_doc_number] => 20110286969
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-24
[patent_title] => 'DEUTERATED COMPOUNDS AS HEPATITIS C VIRUS (HCV) INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/139131
[patent_app_country] => US
[patent_app_date] => 2009-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13778
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20110286969.pdf
[firstpage_image] =>[orig_patent_app_number] => 13139131
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/139131 | DEUTERATED COMPOUNDS AS HEPATITIS C VIRUS (HCV) INHIBITORS | Dec 9, 2009 | Abandoned |
Array
(
[id] => 6501953
[patent_doc_number] => 20100215773
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-26
[patent_title] => 'Use of Quinazoline Derivative ZD6474 Combined With Platinum Compounds and Optionally Ionising Radiation in the Treatment of Diseases Associated With Angiogenesis and/or Increased Vascular Permeability'
[patent_app_type] => utility
[patent_app_number] => 12/624760
[patent_app_country] => US
[patent_app_date] => 2009-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5889
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20100215773.pdf
[firstpage_image] =>[orig_patent_app_number] => 12624760
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/624760 | Use of Quinazoline Derivative ZD6474 Combined With Platinum Compounds and Optionally Ionising Radiation in the Treatment of Diseases Associated With Angiogenesis and/or Increased Vascular Permeability | Nov 23, 2009 | Abandoned |
Array
(
[id] => 7669156
[patent_doc_number] => 20110318425
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-29
[patent_title] => 'TREATMENT OF INTERSTITIAL CYSTITIS USING (6aR, 10aR)- DELTA-8-TETRAHDRAOCANNABINOL-11-OIC ACIDS'
[patent_app_type] => utility
[patent_app_number] => 12/624313
[patent_app_country] => US
[patent_app_date] => 2009-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8729
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12624313
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/624313 | Treatment of interstitial cystitis using (6aR, 10aR)-Δ8-tetrahydrocannabinol-11-OIC acids | Nov 22, 2009 | Issued |
Array
(
[id] => 6302799
[patent_doc_number] => 20100068292
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-18
[patent_title] => 'Novel Inhibitors of Arachidonic Acid Formation'
[patent_app_type] => utility
[patent_app_number] => 12/619904
[patent_app_country] => US
[patent_app_date] => 2009-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2213
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20100068292.pdf
[firstpage_image] =>[orig_patent_app_number] => 12619904
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/619904 | Novel Inhibitors of Arachidonic Acid Formation | Nov 16, 2009 | Abandoned |
Array
(
[id] => 7574143
[patent_doc_number] => 20110269799
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-03
[patent_title] => 'METHOD FOR TREATING OR PREVENTING THROMBOSIS USING DABIGATRAN ETEXILATE OR A SALT THEREOF WITH IMPROVED EFFICACY OVER CONVENTIONAL WARFARIN THERAPY'
[patent_app_type] => utility
[patent_app_number] => 13/128460
[patent_app_country] => US
[patent_app_date] => 2009-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 20340
[patent_no_of_claims] => 76
[patent_no_of_ind_claims] => 36
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20110269799.pdf
[firstpage_image] =>[orig_patent_app_number] => 13128460
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/128460 | METHOD FOR TREATING OR PREVENTING THROMBOSIS USING DABIGATRAN ETEXILATE OR A SALT THEREOF WITH IMPROVED EFFICACY OVER CONVENTIONAL WARFARIN THERAPY | Nov 9, 2009 | Abandoned |
Array
(
[id] => 7487529
[patent_doc_number] => 20110251160
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-13
[patent_title] => 'METHOD FOR TREATING OR PREVENTING THROMBOSIS USING DABIGATRAN ETEXILATE OR A SALT THEREOF WITH IMPROVED EFFICACY OVER CONVENTIONAL WARFARIN THERAPY'
[patent_app_type] => utility
[patent_app_number] => 13/128463
[patent_app_country] => US
[patent_app_date] => 2009-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 20731
[patent_no_of_claims] => 73
[patent_no_of_ind_claims] => 31
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0251/20110251160.pdf
[firstpage_image] =>[orig_patent_app_number] => 13128463
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/128463 | METHOD FOR TREATING OR PREVENTING THROMBOSIS USING DABIGATRAN ETEXILATE OR A SALT THEREOF WITH IMPROVED EFFICACY OVER CONVENTIONAL WARFARIN THERAPY | Nov 9, 2009 | Abandoned |
Array
(
[id] => 7574047
[patent_doc_number] => 20110269703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-03
[patent_title] => 'METHOD FOR TREATING OR PREVENTING THROMBOSIS USING DABIGATRAN ETEXILATE OR A SALT THEREOF WITH IMPROVED SAFETY PROFILE OVER CONVENTIONAL WARFARIN THERAPY'
[patent_app_type] => utility
[patent_app_number] => 13/128459
[patent_app_country] => US
[patent_app_date] => 2009-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 20678
[patent_no_of_claims] => 87
[patent_no_of_ind_claims] => 43
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20110269703.pdf
[firstpage_image] =>[orig_patent_app_number] => 13128459
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/128459 | Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved safety profile over conventional warfarin therapy | Nov 9, 2009 | Issued |
Array
(
[id] => 9922361
[patent_doc_number] => 08980317
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-17
[patent_title] => 'Methods and compositions for treating infections comprising a local anesthetic'
[patent_app_type] => utility
[patent_app_number] => 12/614711
[patent_app_country] => US
[patent_app_date] => 2009-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 15
[patent_no_of_words] => 20729
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12614711
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/614711 | Methods and compositions for treating infections comprising a local anesthetic | Nov 8, 2009 | Issued |
Array
(
[id] => 8244611
[patent_doc_number] => 08202532
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-06-19
[patent_title] => 'Clay-based hemostatic agents and devices for the delivery thereof'
[patent_app_type] => utility
[patent_app_number] => 12/611830
[patent_app_country] => US
[patent_app_date] => 2009-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 9
[patent_no_of_words] => 6223
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/202/08202532.pdf
[firstpage_image] =>[orig_patent_app_number] => 12611830
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/611830 | Clay-based hemostatic agents and devices for the delivery thereof | Nov 2, 2009 | Issued |